Main
>
ONCOLOGY (**)
>
Multiple Myeloma R/R ***
>
Treatment
>
ES. P. Plitidepsin+
ES. P. Plitidepsin+'s subsections
(*) AU Approval Date: 2018. 12.11.
+Dexamethasone.
Company
Company Licensee AU, NZ ..
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2018. 12.11.
PR Web-Site
TradeMark
ES. P. Plitidepsin+'s products
This section has no products
(*) AU Approval Date: 2018. 12.11.
+Dexamethasone.
Company
Company Licensee AU, NZ ..
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2018. 12.11.
PR Web-Site
TradeMark